Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Sleep Apnea SyndromesSleep Apnea, Obstructive
Interventions
DRUG

Fentanyl and sevoflurane

DRUG

Remifentanil and desflurane

Trial Locations (1)

1011

CHUV (Centre Hospitalier Universitaire Vaudois), Lausanne

All Listed Sponsors
lead

Centre Hospitalier Universitaire Vaudois

OTHER

NCT02717780 - Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome | Biotech Hunter | Biotech Hunter